| Literature DB >> 19830222 |
William T Harvey, Robert C Bransfield, Dana E Mercer, Andrew J Wright, Rebecca M Ricchi, Mary M Leitao.
Abstract
INTRODUCTION: This review of 25 consecutive patients with Morgellons disease (MD) was undertaken for two primary and extremely fundamental reasons. For semantic accuracy, there is only one "proven" MD patient: the child first given that label. The remainder of inclusive individuals adopted the label based on related descriptions from 1544 through 1884, an internet description quoted from Sir Thomas Browne (1674), or was given the label by practitioners using similar sources. Until now, there has been no formal characterization of MD from detailed examination of all body systems. Our second purpose was to differentiate MD from Delusions of Parasitosis (DP), another "informal" label that fit most of our MD patients. How we defined and how we treated these patients depended literally on factual data that would determine outcome. How they were labeled in one sense was irrelevant, except for the confusing conflict rampant in the medical community, possibly significantly skewing treatment outcomes. CASEEntities:
Year: 2009 PMID: 19830222 PMCID: PMC2737752 DOI: 10.4076/1752-1947-3-8243
Source DB: PubMed Journal: J Med Case Rep ISSN: 1752-1947
Initial Patient Screening Criteria
| 1. Patient convinced of chronic parasite infestation. |
| 2. Primary patient illness focus must be either on dermal sensations or on "never-before-seen" material thought to be extruded from his or her body, even if this was not the most debilitating symptom or sign. The material must have been described as "fibers", "fiber-like", or "filaments". |
| 3. Chronic pruritis (itching) must have been present for at least six months. |
| 4. The patient must have at least two chronic, unhealed skin lesions recorded by a clinician, regardless of whether excoriation was suspected. |
| 5. Prior diagnosis of |
| 6. Patients experiencing delusional states common in withdrawal from drugs such as opiates and patients in organic brain states, were excluded. |
| 7. The illness must have had a life-altering effect on the patient. |
| 8. The patient must be an adult and had experiencing symptoms for more than six months. |
| 9. A healthy pre-morbid period in the patient's life was acceptable. |
Primary Abnormal Findings
| 1. The large age spread, geographic spread and gender neutrality among patients suggest broad human susceptibility to the illness. |
| 2. Rural abode or exposure to unhygienic conditions (third world travel or simply soil exposure) may be risk factors. |
| 3. Onset rate is moderately rapid, without recognizable prodrome, commonly preceded by a healthy state. |
| 4. Once ill, exercise capacity is significantly reduced. |
| 5. The illness is common among family members and close associates, both related genetically and unrelated (such as spouses). |
| 6. Most patients experience weight gain after disease onset. |
| 7. Micro-angiomas appear rapidly on skin after illness onset in most. |
| 8. Fever is recurrent in at least half of those affected. |
| 9. The first illness sign may be the sudden appearance of persistent itching. Ulcerative lesions follow in some cases. |
| 10. Once dermal symptoms begin, patients experience extrusion of unfamiliar material described variously as filamentous, "fuzz balls", black or white "flecks" or "rice grains". |
| 11. Numerous CNS effects occur, that includes bizarre cranial nerve phenomena, anxiety and emotional sequelae. The former tend to be transient. |
| 12. Numerous Peripheral Nervous System findings appear after illness onset. Unlike CNS effects, these are serious, permanent and progressive, and include sensory and motor nerves. |
| 13. All Morgellons have elevated heart rate (>72 BPM) and low body temperature by oral thermometry (<97.5 degrees F). |
| 14. Orthostatic intolerance is intermittent but common in most. |
| 15. Most have some formally diagnosable emotional illness that begins with or becomes apparent after Morgellons disease onset. |
| 16. Endocrine abnormality number and type is higher than background. Most common are Diabetes Type II, Hashimoto's Thyroiditis, hyperparathyroidism and adrenal hypofunction. |
| 17. Most have elevated fasting insulin levels accompanied by elevated TNF-alpha (insulin receptor blocker) [ |
| 18. Common clinical laboratory abnormalities include: |
| a. RBCs have abnormal morphology. On manual examination, RBCs were non-discoid, varied in color and size. |
| b. Natural Killer Cell (CD 56 + CD 16) number and function are very low in most. |
| c. A/G ratio and globulin level are frequently elevated. |
| d. Sedimentation Rate and ANA are extremely low despite other common autoimmune-like conditions. |
| e. Elevated cytokines include: TNF-alpha, IFN-gamma, IL-6, C Reactive Protein, Homocysteine and serum Leptin. |
| 19. Despite no fact-based Case Definition of |